Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 AUD | 0.00% | 0.00% | -62.50% |
May. 24 | The Hydration Pharmaceuticals Postpones Managing Director Appointment | MT |
May. 24 | The Hydration Pharmaceuticals Company Limited Announces Board Change, Effective 25 May 2024 | CI |
Sales 2022 | 9.1M 13.48M | Sales 2023 | 10.04M 14.88M | Capitalization | 4.33M 6.42M |
---|---|---|---|---|---|
Net income 2022 | -10M -14.82M | Net income 2023 | -8M -11.85M | EV / Sales 2022 | 0.99 x |
Net cash position 2022 | 976K 1.45M | Net Debt 2023 | 2.05M 3.04M | EV / Sales 2023 | 0.64 x |
P/E ratio 2022 |
-0.93
x | P/E ratio 2023 |
-0.39
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.37% |
1 month | -30.77% | ||
3 months | -40.00% | ||
6 months | -62.50% | ||
Current year | -62.50% |
Managers | Title | Age | Since |
---|---|---|---|
Oliver Baker
CEO | Chief Executive Officer | - | 17-12-31 |
Chris Kavanaugh
DFI | Director of Finance/CFO | - | 18-04-30 |
Victoria Nadalin
SEC | Corporate Secretary | - | 23-02-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Margaret Hardin
BRD | Director/Board Member | 51 | 22-02-07 |
Adem Karafili
CHM | Chairman | - | 18-10-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-04 | 0.009 | 0.00% | 167,192 |
24-07-03 | 0.009 | 0.00% | 60,344 |
24-06-28 | 0.009 | 0.00% | 103,448 |
24-06-27 | 0.009 | 0.00% | 66,678 |
Delayed Quote Australian S.E., July 03, 2024 at 09:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-62.50% | 1.85M | |
+56.89% | 809B | |
+39.52% | 624B | |
-6.55% | 351B | |
+7.92% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 166B | |
-2.57% | 157B |
- Stock Market
- Equities
- HPC Stock